Breaking News - The Fly

Open Search

VRDN

Viridian Therapeutics

$

()

Foghorn Therapeutics appoints Humer as Chief Financial Officer

FHTX , VRDN

4/16/2024 - 07:09am

Viridian Therapeutics price target lowered by $4 at B. Riley, here's why

VRDN , SLRN

3/21/2024 - 08:46am

Viridian Therapeutics price target lowered by $2 at Wells Fargo, here's why

VRDN , SLRN

2/29/2024 - 06:16am

Viridian Therapeutics price target raised by $1 at Wedbush, here's why

VRDN

2/28/2024 - 08:49am

Viridian Therapeutics price target lowered by $1 at JMP Securities, here's why

VRDN

2/28/2024 - 06:44am

Viridian Therapeutics expects cash to fund operations into second half of 2026

VRDN

2/27/2024 - 16:08pm

Viridian Therapeutics reports Q4 EPS ($1.35), consensus ($1.00)

VRDN

2/27/2024 - 16:07pm

Viridian Therapeutics names Jennifer Tousignant chief legal officer

VRDN , SANA

2/16/2024 - 08:06am

Viridian Therapeutics price target lowered by $1 at Wedbush, here's why

VRDN

1/22/2024 - 08:31am

Viridian Therapeutics 7.14M share Spot Secondary priced at $21.00

VRDN

1/17/2024 - 22:45pm

Viridian announces offering of common stock, Series B preferred stock

VRDN

1/17/2024 - 16:05pm

Spyre Therapeutics price target raised by $9 at Stifel, here's why

SYRE , APGE , VRDN

…

1/12/2024 - 07:36am

Apogee Therapeutics price target raised by $12 at Stifel, here's why

APGE , VRDN , GSK

…

1/12/2024 - 07:35am

Short Report: Bears boost exposure to Rocket Companies despite dovish Fed tilt

RKT , BIRK , VRDN

…

12/22/2023 - 13:16pm

Viridian Therapeutics price target raised to $36 from $35 at Oppenheimer

VRDN , AMGN

12/19/2023 - 07:27am